Continuing Education Activity

The ketogenic diet is a high-fat, very low-carbohydrate nutritional pattern that promotes a metabolic shift from glucose utilization to ketone production, supporting energy needs during carbohydrate restriction. The diet reduces circulating insulin levels, enhances fat oxidation, and induces ketosis, creating physiologic conditions that may benefit individuals with epilepsy, obesity, type 2 diabetes, and certain metabolic disorders. Originally developed as a therapy for refractory epilepsy in children, the ketogenic diet is now incorporated into broader clinical practice as evidence accumulates regarding its metabolic, neurologic, and endocrine effects. The diet’s physiologic impact includes alterations in mitochondrial function, modulation of neuronal excitability, and changes in gut microbiota, all of which contribute to its therapeutic potential. Clinicians frequently encounter challenges related to patient selection, monitoring requirements, safety considerations, and long-term adherence, making a structured understanding of its mechanisms and clinical applications essential for optimal patient care.

This activity for healthcare professionals enhances the learner’s competence by providing a comprehensive foundation in the mechanisms, clinical indications, and safety considerations of ketogenic therapy. Participants learn to assess appropriate candidates, counsel patients on dietary composition, anticipate and manage adverse effects, and integrate evidence-based strategies into individualized treatment plans. The course also strengthens skills in monitoring metabolic parameters and adjusting therapy based on clinical response. Collaboration among an interprofessional team—including clinicians, dietitians, pharmacists, and nurses—supports coordinated patient education, reinforces adherence, and improves safety, thereby promoting favorable long-term outcomes. 

Objectives:

• Compare the ketogenic diet with other dietary approaches by examining differences in macronutrient composition, underlying metabolic mechanisms, and related health benefits and risks.
• Identify patients with contraindications or those needing personalized adjustments and close monitoring before initiating the ketogenic diet.
• Assess and monitor patients' progress by tracking weight changes, metabolic markers, and potential adverse effects related to the ketogenic diet.
• Collaborate within the interprofessional healthcare team, including physicians, dietitians, nurses, and pharmacists, to coordinate patient education, track outcomes, and ensure the safe, evidence-based implementation of the ketogenic diet.

Introduction

The ketogenic diet is a high-fat, very low-carbohydrate, and moderate-protein dietary approach designed to induce nutritional ketosis. In this metabolic state, the body shifts from glucose to ketone bodies as its primary energy source. Typical macronutrient distribution includes about 55% to 60% fat, 30% to 35% protein, and 5% to 10% carbohydrates.[1] This shift alters glucose utilization, enhances ketone production, and improves insulin sensitivity, which underlie the ketogenic diet's therapeutic and metabolic benefits.   

Before the discovery of insulin in the 1920s, managing type 1 diabetes mainly involved very low-carbohydrate, low-calorie diets that were essentially ketogenic. These diets aimed to prolong survival by reducing glycosuria and hyperglycemia but often caused severe malnutrition and growth impairment, especially in children. The introduction of exogenous insulin in the 1920s replaced dietary measures as the primary treatment for diabetes. Russell Wilder, MD of the Mayo Clinic, first used the ketogenic diet to treat epilepsy in 1921.[1] He coined the term "ketogenic diet" and observed that it reduced the frequency and severity of seizures in some of his patients who followed it. The ketogenic diet saw a decline in clinical use after the discovery of insulin and the development of anticonvulsant medications.[2] The diet's resurgence in the 1990s was driven by renewed success in treating refractory epilepsy, later expanding to include treating a range of cardiometabolic and neurologic conditions.

Today, the ketogenic diet is studied and used in various clinical and research settings, including obesity, metabolic syndrome, and type 2 diabetes, with growing interest in areas like cancer metabolism and neurodegenerative diseases, including Parkinson disease and Alzheimer disease.[3][4][5] Multiple randomized controlled trials and meta-analyses have demonstrated its effectiveness for weight loss and blood sugar control in obesity and type 2 diabetes, resulting in reductions in body mass index, hemoglobin A1c, and triglycerides, and increased high-density lipoprotein cholesterol.[6] Further evidence indicates improvements in insulin sensitivity and metabolic parameters in metabolic syndrome.[4] 

Although current use of the ketogenic diet includes metabolic and neurologic disorders, epilepsy remains its only universally accepted, guideline-supported indication. The diet is well established in managing drug-resistant epilepsy, glucose transporter type 1 deficiency syndrome, and pyruvate dehydrogenase deficiency, where it can substantially reduce seizure frequency and severity.[7] Emerging applications in obesity, diabetes, metabolic dysfunction–associated steatotic liver disease, and neurodegenerative conditions remain investigational and lack guidelines from professional medical organizations. Other areas of investigation include supportive therapy for certain cancers, polycystic ovary syndrome, and psychiatric conditions, but current evidence is limited.[2]

Three principal forms of the ketogenic diet are used in clinical practice, differing in composition, level of restriction, and therapeutic goals.

• The traditional ketogenic diet, initially developed for treating drug-resistant epilepsy (especially in children), is a ratio-based plan where the amount of fat relative to combined protein and carbohydrate is typically 4:1; in some cases, a 3:1 ratio can be used. About 90% of total calories come from fat, with approximately 6% from protein and 4% from carbohydrates. This diet requires precise food weighing and close supervision by medical professionals and dietitians to maintain ketosis. The main goal is to achieve and sustain high, stable ketone levels to reduce seizure frequency and severity.
• The modified Atkins diet provides a less restrictive alternative, often used for adolescents and adults with epilepsy or when strict adherence to the traditional plan is difficult. This diet employs an approximate 1:1 ratio of fat to combined protein and carbohydrates by weight, resulting in roughly 60% to 70% of calories from fat, 25% to 30% from protein, and 5% to 10% from carbohydrates (usually less than 20 grams daily). Foods do not need to be weighed, making this approach more straightforward to implement while still promoting nutritional ketosis.
• The very-low-carbohydrate ketogenic diet is most often prescribed for obesity, type 2 diabetes, and metabolic syndrome. Instead of following a fixed macronutrient ratio, it limits carbohydrate intake to 20 to 50 grams daily, with moderate protein and 60% to 75% of calories from fat. This dietary pattern emphasizes carbohydrate restriction as the primary driver of ketosis, offering greater flexibility and long-term sustainability. The primary clinical goals are weight loss, improved insulin sensitivity, and favorable metabolic effects.[8]

This educational activity explores the physiological mechanisms, clinical applications, and potential risks of the ketogenic diet, along with team-based strategies for its implementation, emphasizing evidence-based, patient-centered care across healthcare professions.

Function

The ketogenic diet works by significantly reducing carbohydrate intake and increasing fat intake, shifting the body's primary energy source from glucose to ketone bodies produced by the liver. When daily carbohydrate intake falls below roughly 20 to 50 grams, the resulting decrease in insulin levels triggers increased lipolysis and the release of free fatty acids from adipose stores. These fatty acids are then transported to the liver, where they are converted into ketone bodies, such as β-hydroxybutyrate, acetoacetate, and acetone. When glucose availability is limited, these ketone bodies serve as alternative energy sources for the brain, muscles, and other tissues.[9]

Mechanisms of Action

1. Metabolic shift and energy substitution When carbohydrate intake is restricted, hepatic gluconeogenesis maintains glucose supply by using pyruvate, lactate, glycerol, and glucogenic amino acids.[10][11] As endogenous glucose production becomes insufficient to meet energy demands, the body transitions to ketogenesis, producing acetoacetate, beta-hydroxybutyrate, and acetone as alternative energy sources. Insulin secretion decreases as blood glucose falls, suppressing glycogen and fat storage while promoting lipolysis and fatty acid oxidation. Nutritional ketosis, with a normal blood pH, differs from ketoacidosis, which is characterized by metabolic acidosis.[10]

2. Cellular energy efficiencyKetone bodies act as high-efficiency fuel for the heart, skeletal muscle, and kidneys, and cross the blood–brain barrier to support neuronal metabolism.[12] Red blood cells and hepatocytes, lacking mitochondria and the enzyme diaphorase, cannot utilize ketones.[13] Compared to glucose, ketones yield more adenosine triphosphate (ATP)—approximately 9400 g ATP per 100 g acetoacetate and 10,500 g ATP per 100 g beta-hydroxybutyrate, versus 8700 g ATP per 100 g glucose—making them an energetically advantageous substrate. Ketones also reduce free radical formation and enhance antioxidant capacity, improving cellular resilience.[12][14]

3. Signaling and regulatory effects Beyond energy metabolism, ketone bodies function as signaling molecules that influence gene expression, inflammation, and neurotransmitter balance. For example, β-hydroxybutyrate inhibits histone deacetylases, activating epigenetic and anti-inflammatory pathways.[9][15] Ketosis modulates hormonal and metabolic profiles, lowering glucose and insulin levels, improving lipid metabolism, and influencing adipose tissue function.

4. Neurological stabilityIn neurological disorders, ketosis, through mechanisms that are not yet fully understood, enhances mitochondrial efficiency and inhibits excitatory synaptic transmission, decreasing the frequency and severity of seizures in drug-resistant epilepsy, glucose transporter type 1 deficiency, and pyruvate dehydrogenase deficiency.[8]       

In summary, the ketogenic diet causes a fundamental shift in metabolism and hormone levels, replacing glucose with ketones as the body's primary fuel. This change improves energy efficiency, alters cellular signaling, and stabilizes neuronal activity—mechanisms that support its therapeutic benefits in epilepsy, metabolic disease, and emerging investigational uses.

Issues of Concern

The following are issues of concern with the ketogenic diet:

Adverse Effects

The ketogenic diet can cause various adverse effects, ranging in severity and duration, with gastrointestinal, metabolic, and nutritional problems being the most common. Short-term adverse effects often include nausea, vomiting, constipation, diarrhea, halitosis, headache, fatigue, dizziness, and transient hypoglycemia. These usually occur during the early adaptation phase and tend to resolve within days to weeks. These symptoms are sometimes called the "keto flu" and are likely due to carbohydrate withdrawal, shifts in fluid and electrolyte balance, and the metabolic transition to ketosis. The severity and duration of the "keto flu" vary, but symptoms generally improve as the body adjusts to ketosis.[16][17][18][19] The symptoms are usually mild and can be managed by ensuring adequate hydration and electrolyte intake. However, more severe adverse effects occasionally lead to emergency department visits and hospitalizations for dehydration, electrolyte imbalances, and hypoglycemia.[20][21][22]

Gastrointestinal complaints affect about half of patients starting the ketogenic diet and are a significant reason for early discontinuation or dietary modification. In addition to the symptoms listed above, patients may experience abdominal pain and reflux. Most of these disturbances improve with adequate hydration, fiber optimization, and timely use of supportive therapies such as laxatives, stool softeners, antiemetics, or acid-reducing medications.[17]

Although long-term safety data are limited, reported complications include dyslipidemia, hepatic steatosis, cardiomyopathy, hypercalciuria and kidney stones, reduced bone mineral density, and growth impairment in children.[23] In a study of pediatric patients with intractable epilepsy, the results showed that those treated with the ketogenic diet had lower height, weight, and body mass index after 2 years compared to the control diet group.[18][24] Chronic use has been associated with deficiencies in multiple micronutrients—including vitamins, minerals, and phytochemicals—as well as hypoproteinemia, all of which may contribute to renal and skeletal complications. Individuals following the ketogenic diet generally benefit from routine vitamin and mineral supplementation.[19][25] 

Aside from metabolic problems, other concerns include increased cardiovascular risk from high saturated fat intake and decreased dietary fiber, both of which may negatively affect lipid profiles and endothelial function. Evidence is mixed regarding the effects on low-density lipoprotein cholesterol levels, with some studies reporting increases. There is no conclusive evidence of benefits regarding the impact on other markers of cardiometabolic risk factors.[26] 

Cautions and Contraindications

Patients with diabetes who use insulin or oral hypoglycemic agents such as sulfonylureas are at heightened risk for significant hypoglycemia when initiating the ketogenic diet, and their medication regimens typically require close monitoring and careful dose reduction. Hypoglycemia occurs when a rapid decrease in carbohydrate intake lowers blood glucose levels and lowers insulin requirements.[27] Individuals with diabetes who use sodium–glucose cotransporter 2 (SGLT2) inhibitors should avoid the ketogenic diet, as the combination substantially increases the risk of euglycemic diabetic ketoacidosis (DKA). This potentially life-threatening complication can develop despite normal or only mildly elevated glucose levels. SGLT2 inhibitors promote ketone production by raising glucagon, lowering insulin, and enhancing lipolysis, and carbohydrate restriction from the ketogenic diet further intensifies ketosis. Together, these mechanisms can precipitate DKA that is more difficult to detect and more likely to arise during fasting, illness, or other periods of reduced carbohydrate intake.[28] The ketogenic diet is contraindicated in individuals with acute or chronic pancreatitis, liver failure, fat-metabolism disorders (such as primary carnitine deficiency, carnitine palmitoyltransferase deficiency, and carnitine translocase deficiency), porphyrias, and pyruvate kinase deficiency. These contraindications are due to the risk of metabolic decompensation or inability to use fat as an energy source, which can be life-threatening in these populations.[29][30] 

The ketogenic diet is not recommended during pregnancy, as severe carbohydrate restriction may impair fetal growth, increase the risk of nutrient deficiencies, and has not been proven safe in this population. The diet is also contraindicated in patients with a history of eating disorders, where rigid dietary rules and rapid weight changes can precipitate relapse or exacerbate disordered eating behaviors. Rarely, individuals following the ketogenic diet may receive a false positive on a breath alcohol test. This result occurs because acetone, a ketone body produced during ketosis, is converted to isopropanol by hepatic alcohol dehydrogenase and can be detected by some breathalyzers as ethanol or isopropanol, leading to an inaccurate reading. Current law enforcement and clinical breathalyzer devices are much less likely than older models to misinterpret ketosis-related breath acetone as alcohol.[31][32] 

Compliance and Sustainability

Maintaining long-term adherence to the ketogenic diet is difficult because its strict macronutrient restrictions can be hard to follow in daily life. Social events, family meals, cultural food traditions, limited food choices, and the need for constant meal planning often reduce sustainability and lead to high dropout rates over time. A 2024 review of ketogenic dietary therapy for epilepsy found mean adherence rates in the first year of approximately 70% in children, 65% in adolescents, and 64% in adults. In the same review, mean adherence dropped to 38% at 3 years.[33] Reasons to discontinue the diet included caregiver burden, children's refusal to eat the low-carbohydrate food, lack of motivation, difficulty with the restrictive nature of the diet, and complications or lack of efficacy in controlling seizures.[33][34]

High attrition rates have also been documented in weight-loss programs using the ketogenic diet. In a 9-month personalized ketogenic intervention, retention decreased from nearly complete participation at 3 months to only 23% at 6 months and 8.4% at 9 months, mainly due to perceived diet monotony, psychological fatigue, social pressures, and the overall restrictive nature of the diet.[35] Better retention is seen when patients have strong caregiver or family support, help with meal preparation, and access to behavioral or nutritional counseling, particularly when they perceive clear health or personal benefits from the diet. 

Monitoring

Monitoring is essential when patients start or continue the ketogenic diet, as its metabolic effects can impact multiple organs and interact with concomitant therapies. Clinicians should regularly assess renal function, as ketosis and high protein intake may increase kidney workload, especially in those with pre-existing kidney disease. A fasting lipid profile is essential to monitor, as low-density lipoprotein cholesterol and triglycerides may rise in some patients, particularly shortly after starting the diet. Electrolyte levels (including sodium, potassium, magnesium, and bicarbonate) should be checked periodically, as fluid balance and acid–base status can change with carbohydrate restriction. Finally, patients with diabetes or hypertension often need medication adjustments—glucose-lowering drugs may need to be reduced to prevent hypoglycemia, and antihypertensive doses might need to be modified as weight loss and diuresis help control blood pressure. 

Evidence gaps 

The long-term effects of the pre-existing conditions are still not fully understood, with significant evidence gaps across multiple areas despite clear short-term benefits. While the ketogenic diet is linked to weight loss, better glycemic control, reductions in triglycerides, seizure reduction, and potential neuroprotective effects in neurological conditions, most clinical trials are short (usually less than a year), and data on long-term outcomes are limited. Significant gaps remain in our understanding of cardiovascular results. Although short-term improvements in lipid profiles and metabolic markers have been documented, the long-term risk of atherosclerotic events or adverse cardiovascular outcomes remains unknown.[2][8][36] Similarly, data on renal, endocrine, and hepatic function are limited; reports of increased renal workload from a higher protein intake, hepatic steatosis, and impaired insulin secretion exist, but few studies examine major renal or hepatic outcomes over extended periods.[37]

Results from short-term studies in adults suggest that the ketogenic diet generally does not significantly affect bone mineral density or bone turnover in typical weight-loss settings. However, evidence from elite athletes and adults with epilepsy indicates that the ketogenic diet may impair bone remodeling and calcium metabolism, reducing bone formation markers and potentially harming bone health, especially in younger adults and individuals with higher body mass index. Animal studies also suggest that chronic metabolic acidosis may contribute to bone loss. Overall, the ketogenic diet may pose a risk to bone health for vulnerable groups. Long-term data remain limited, and further investigation is needed.[38][39]

The impact of prolonged carbohydrate restriction on cognitive function remains a significant practice gap. While short-term improvements in attention or seizure-related cognition are observed in children with seizure disorders, there is a lack of long-term data in adults, and the potential effects of extended ketosis on brain function are still unclear.[40] Additionally, some evidence suggests potential neuroprotective effects in Alzheimer and Parkinson disease, with study results indicating improvements in cognitive function and a slowing of disease progression.[4]

Overall, while the ketogenic diet offers promising short-term benefits for specific populations, most clinical trials are brief—typically less than a year—and lack evidence of long-term safety and effectiveness. These gaps underscore the need for more high-quality, long-term studies to assess the safety and functional effects of the ketogenic diet over time. Further research with larger groups and extended follow-up is necessary to address current gaps and deepen our understanding of the overall health effects of the ketogenic diet.[4]

Clinical Significance

Patient Selection and Clinical Indications

The ketogenic diet may be appropriate for a range of patients with various clinical conditions, although benefits vary by population and depend heavily on adherence and comorbidities. The diet has the strongest evidence base in drug-resistant epilepsy, with consistent reductions in seizure burden and improved neurologic stability across pediatric and adult populations. Patients with glucose transporter type 1 deficiency or pyruvate dehydrogenase deficiency also derive clear therapeutic benefit and remain high-priority candidates for the ketogenic diet.[41]

In obesity, metabolic syndrome, and type 2 diabetes, the ketogenic diet is associated with clinically meaningful improvements in weight, triglycerides, insulin sensitivity, fasting glucose, and diastolic blood pressure compared with low-fat diets.[42][43] This diet may be beneficial for individuals with severe obesity, hypertriglyceridemia, or poor glycemic control when other dietary approaches have been ineffective or poorly tolerated. A randomized crossover trial in type 2 diabetes demonstrated significant reductions in body weight and improved glucose regulation, although effects on HbA1c were modest, and adherence remained a challenge.[44] 

Individuals following the ketogenic diet typically experience rapid weight loss, often up to 10 pounds in the first 2 weeks. This initial weight loss is attributed to the diet's diuretic effect; the loss of water weight is followed by fat loss and preservation of lean body mass. As nutritional ketosis continues, hunger decreases, and an overall reduction in caloric intake aids in further weight loss.

Some meta-analyses and reviews suggest that the ketogenic diet may improve certain cardiovascular risk factors, such as systemic inflammation and vascular endothelial function, but the long-term cardiovascular benefits remain uncertain.[41] Patients with polycystic ovarian syndrome may also benefit. Trials comparing the ketogenic diet with other dietary strategies show improvements in fasting insulin, glycemic measures, and androgen levels, supporting its use when MASLD or insulin resistance predominates.[45]

Emerging evidence suggests the ketogenic diet may help select patients with neurodegenerative diseases, including Alzheimer disease and Parkinson disease, where preliminary studies report improvements in oxidative stress, mitochondrial function, and certain cognitive or motor symptoms.[42][46] Although data remain limited, patients with mild disease, preserved functional status, and strong caregiver support may be reasonable candidates for supervised ketogenic diet trials.

The ketogenic diet demonstrates encouraging mechanistic and preclinical potential as an adjunct to cancer therapy; however, its clinical efficacy remains unproven, and routine use outside of research settings is not recommended. This diet may have anti-tumor effects in cancers such as neuroblastoma, acute myeloid leukemia, and glioblastoma by creating a metabolic environment that activates GPR109A, inhibits mechanistic target of rapamycin complex 1, and decreases glucose uptake and glycolysis in tumors. These effects could slow tumor growth, improve the effectiveness of chemotherapy, and increase survival. Although these findings offer a rationale for the ketogenic diet as an additional therapy, clinical evidence in humans remains limited, and further studies are necessary to determine its role.[47][48]

Across all indications, patients most likely to benefit are those with:

• Metabolic or neurologic conditions known to respond to carbohydrate restriction
• Sufficient motivation, family support, and meal-planning capacity
• The ability to comply with structured follow-up and laboratory monitoring
• No major contraindications, including significant hepatic, renal, or pancreatic disease

Implementing the Ketogenic Diet

In recent years, ketogenic diets have gained widespread popularity in the lay press and on social media, often promoted not only for weight loss but also for enhanced energy, mental clarity, and improved insulin sensitivity. Much of this enthusiasm is driven by anecdotal reports and marketing rather than robust, large-scale clinical evidence. Although short-term benefits have been documented, the ketogenic diet's long-term safety and sustainability remain under investigation.

For safe and effective implementation, clinicians can provide structured examples of ketogenic meal plans that illustrate appropriate macronutrient distribution and caloric intake, offering evidence-based guidance rather than leaving patients to navigate social media advice. A one-day sample diet for an adult following a very-low-carbohydrate ketogenic diet (20–50 g carbs/day, moderate protein, and 60%–75% calories from fat) for weight loss and improved metabolic health can be structured as follows:

Breakfast:

• 2 eggs scrambled in olive oil with spinach and feta cheese
• 1/2 avocado
• Black coffee or unsweetened tea

(~5 g net carbs, high fat, moderate protein)

Lunch:

• Grilled salmon fillet (120–150 g)
• Mixed leafy greens (arugula, romaine, cucumber) with olive oil and lemon dressing
• 10 olives

(~6 g net carbs, high fat, moderate protein) 

Snack: 

• 30 g macadamia nuts or walnuts

         (~2 g net carbs, high fat)

Dinner:

• Roasted chicken thigh (skin-on)
• Sautéed broccoli and cauliflower in butter
• 1 tablespoon pesto sauce

        (~7 g net carbs, high fat, moderate protein)

Optional evening snack: 

• 30 g full-fat cheese

       (~1 g net carbs) 

Total:

• Carbohydrates: 20 to 25 g net carbs
• Protein: Moderate (1–1.5 g/kg ideal body weight/day)
• Fat: 60% to 75% of total calories, primarily from unsaturated sources (olive oil, nuts, fatty fish)

This sample aligns with clinical recommendations for ketogenic diets, emphasizing non-starchy vegetables, healthy fats, and moderate protein.[8][49] The National Lipid Association and recent randomized controlled trials recommend prioritizing unsaturated fats (olive oil, nuts, fatty fish) over saturated fats to minimize adverse lipid effects.[26] The American Diabetes Association also notes that such patterns can improve weight and metabolic parameters, advising ongoing medical supervision, especially for patients with diabetes or on glucose-lowering medication.[28] Practical pointers for patients who begin the ketogenic diet include limiting grains, starchy vegetables, sugars, and most fruits, while focusing on leafy greens, cruciferous vegetables, avocados, olives, nuts, seeds, eggs, fatty fish, poultry, and full-fat dairy products. 

Patients may inquire about drinking "bulletproof" coffee, a blend of coffee, butter, and medium-chain triglycerides (MCTs). This beverage raises ketone levels because the liver rapidly converts MCTs to ketones, but its clinical value in treating obesity, diabetes, and metabolic syndrome is likely limited. Nutritionally, bulletproof coffee is high in saturated fat but lacks protein, fiber, and micronutrients, making it unsuitable for meal replacement and concerning for its potential to increase cardiovascular risk.[50]  

Risk-Benefit Assessment and Clinical Monitoring

The ketogenic diet requires individualized assessment. Patients with obesity or diabetes may experience substantial metabolic improvement, whereas those with baseline dyslipidemia or hepatic steatosis may be at risk for mixed cardiometabolic responses.[42][43] In MASLD, microbiome and metabolic changes may reduce inflammation. Still, high dietary fat intake can worsen steatosis in some individuals, underscoring the need for careful monitoring.[2] Medication adjustments are often required, particularly for patients with diabetes (risk of hypoglycemia) and hypertension (natriuresis-related blood pressure reduction). Periodic monitoring of renal function, electrolytes, liver enzymes, and lipid profiles supports safe continuation of the ketogenic diet.  

Practical Counseling and Follow-Up Strategies

Because the ketogenic diet is highly restrictive, counseling should focus on expectation-setting, potential adverse effects, and strategies to maintain adherence. The literature consistently reports high rates of discontinuation, even among patients who show early metabolic improvements.[44] Regular follow-up enhances safety, reinforces dietary accuracy, bolsters motivation, and facilitates timely medication adjustments.

Meta-analyses show the ketogenic diet results in greater long-term weight loss than low-fat diets and leads to favorable changes in triglycerides and high-density lipoprotein-C. Still, it may raise low-density lipoprotein cholesterol, which can affect long-term cardiovascular health.[43] Clinicians should establish clear objectives for weight loss, glycemic control, lipid improvement, or seizure reduction, and periodically reassess the risk–benefit balance. Shared decision-making coupled with dietary adjustments, including shifts to less restrictive low-carbohydrate patterns, can promote sustained adherence without compromising clinical benefits.

Enhancing Healthcare Team Outcomes

Optimal outcomes for individuals following the ketogenic diet rely on a coordinated, collaborative approach involving multiple disciplines. Each interprofessional team member plays a distinct yet complementary role:

• Physicians and advanced practice clinicians

  • Assess patient suitability for the KD
  • Initiate therapy and manage comorbidities
  • Supervise laboratory monitoring
• Registered dietitians

  • Provide individualized meal planning
  • Ensure adequate micronutrient intake
  • Adjust diet as needed to promote long-term adherence
• Nurses

  • Reinforce patient education
  • Monitor tolerance and adherence
  • Identify early adverse effects
• Pharmacists

  • Review medication–ketosis interactions, especially insulin or diuretics
  • Recommend adjustment to therapies as needed
• Behavioral health professionals and social workers

  • Address psychological barriers and motivation
  • Provide strategies to enhance long-term adherence

Effective interprofessional communication, including shared electronic health record documentation, coordinated patient messaging, and structured follow-up, ensures consistent care and improves patient safety. Attention to patient-centered factors, such as individual preferences, cultural considerations, and dietary accessibility, further enhances engagement. By integrating these roles, the team can strengthen performance, better monitor clinical outcomes (eg, weight trends, glycemic and lipid parameters, symptom tracking), and support sustainable, evidence-based ketogenic therapy for conditions such as epilepsy, obesity, type 2 diabetes, MASLD, and neurodegenerative diseases.[2][41][42][43]. Coordinated interprofessional care is vital to maximizing the safety, adherence, and clinical effectiveness of the ketogenic diet across diverse patient populations.

Review Questions

• Access free multiple choice questions on this topic.
• Comment on this article.

References

1.

Kim JM. Ketogenic diet: Old treatment, new beginning. Clin Neurophysiol Pract. 2017;2:161-162. [PMC free article: PMC6123870] [PubMed: 30214990]

2.

Zhu H, Bi D, Zhang Y, Kong C, Du J, Wu X, Wei Q, Qin H. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct Target Ther. 2022 Jan 17;7(1):11. [PMC free article: PMC8761750] [PubMed: 35034957]

3.

Luong T, Svart M, Gormsen LC, Søndergaard E. Ketogenic diet in the management of disease. Curr Opin Clin Nutr Metab Care. 2025 Nov 01;28(6):477-482. [PubMed: 40779172]

4.

Chamma L, Chamma N, Mattar L, Slaybe M, Haidar S, Rizk R. Beyond epilepsy management: A narrative review of the health effects of ketogenic diets. Nutrition. 2025 Sep;137:112804. [PubMed: 40403346]

5.

McDonald TJW, Cervenka MC. Lessons learned from recent clinical trials of ketogenic diet therapies in adults. Curr Opin Clin Nutr Metab Care. 2019 Nov;22(6):418-424. [PMC free article: PMC7881369] [PubMed: 31503023]

6.

Choi YJ, Jeon SM, Shin S. Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Nutrients. 2020 Jul 06;12(7) [PMC free article: PMC7400909] [PubMed: 32640608]

7.

Cameron T, Allan K, Kay Cooper The use of ketogenic diets in children living with drug-resistant epilepsy, glucose transporter 1 deficiency syndrome and pyruvate dehydrogenase deficiency: A scoping review. J Hum Nutr Diet. 2024 Aug;37(4):827-846. [PubMed: 38838079]

8.

Yannakoulia M, Scarmeas N. Diets. N Engl J Med. 2024 Jun 13;390(22):2098-2106. [PubMed: 38865662]

9.

Longo R, Peri C, Cricrì D, Coppi L, Caruso D, Mitro N, De Fabiani E, Crestani M. Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry. Nutrients. 2019 Oct 17;11(10) [PMC free article: PMC6836190] [PubMed: 31627352]

10.

Jagadish S, Payne ET, Wong-Kisiel L, Nickels KC, Eckert S, Wirrell EC. The Ketogenic and Modified Atkins Diet Therapy for Children With Refractory Epilepsy of Genetic Etiology. Pediatr Neurol. 2019 May;94:32-37. [PubMed: 30803845]

11.

Mohorko N, Černelič-Bizjak M, Poklar-Vatovec T, Grom G, Kenig S, Petelin A, Jenko-Pražnikar Z. Weight loss, improved physical performance, cognitive function, eating behavior, and metabolic profile in a 12-week ketogenic diet in obese adults. Nutr Res. 2019 Feb;62:64-77. [PubMed: 30803508]

12.

Dhillon KK, Gupta S. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Feb 6, 2023. Biochemistry, Ketogenesis. [PubMed: 29630231]

13.

Hernández F. Glycolysis and gluconeogenesis: A teaching view. J Biol Chem. 2021 Jan-Jun;296:100016. [PMC free article: PMC8289105] [PubMed: 33410396]

14.

Mooli RGR, Ramakrishnan SK. Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease. Front Physiol. 2022;13:946474. [PMC free article: PMC9289363] [PubMed: 35860662]

15.

Spigoni V, Cinquegrani G, Iannozzi NT, Frigeri G, Maggiolo G, Maggi M, Parello V, Dei Cas A. Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders. Front Endocrinol (Lausanne). 2022;13:972890. [PMC free article: PMC9631778] [PubMed: 36339405]

16.

Meng Y, Sun J, Zhang G. Take the bull by the horns and tackle the potential downsides of the ketogenic diet. Nutrition. 2024 Sep;125:112480. [PubMed: 38788511]

17.

Sepehrar S, Sadeghi T, Kossoff E, Nikoonia M, Zarei M, Toosi MB, Talebi S. Short and long-term side effects of the Classic Ketogenic Diet in pediatric epilepsy treatment: A systematic review of clinical trials. Seizure. 2025 Sep;131:382-390. [PubMed: 40834684]

18.

Kang HC, Chung DE, Kim DW, Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia. 2004 Sep;45(9):1116-23. [PubMed: 15329077]

19.

Luong TV, Abild CB, Bangshaab M, Gormsen LC, Søndergaard E. Ketogenic Diet and Cardiac Substrate Metabolism. Nutrients. 2022 Mar 22;14(7) [PMC free article: PMC9003554] [PubMed: 35405935]

20.

Włodarek D. Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease). Nutrients. 2019 Jan 15;11(1) [PMC free article: PMC6356942] [PubMed: 30650523]

21.

Guzel O, Uysal U, Arslan N. Efficacy and tolerability of olive oil-based ketogenic diet in children with drug-resistant epilepsy: A single center experience from Turkey. Eur J Paediatr Neurol. 2019 Jan;23(1):143-151. [PubMed: 30497921]

22.

Armeno M, Araujo C, Sotomontesano B, Caraballo RH. [Update on the adverse effects during therapy with a ketogenic diet in paediatric refractory epilepsy]. Rev Neurol. 2018 Mar 16;66(6):193-200. [PubMed: 29537059]

23.

Ruiz Herrero J, Cañedo Villarroya E, García Peñas JJ, García Alcolea B, Gómez Fernández B, Puerta Macfarland LA, Pedrón Giner C. Safety and Effectiveness of the Prolonged Treatment of Children with a Ketogenic Diet. Nutrients. 2020 Jan 24;12(2) [PMC free article: PMC7071522] [PubMed: 31991539]

24.

Menzies J, Sundararaj A, Cardamone M, McHarg A, Leach S, Krishnan U. Ketogenic Diets in Children With Intractable Epilepsy and its Effects on Gastrointestinal Function, Gut Microbiome, Inflammation, and Quality of Life. J Pediatr Gastroenterol Nutr. 2023 Nov 01;77(5):679-685. [PubMed: 37679873]

25.

O'Neill B, Raggi P. The ketogenic diet: Pros and cons. Atherosclerosis. 2020 Jan;292:119-126. [PubMed: 31805451]

26.

Kirkpatrick CF, Bolick JP, Kris-Etherton PM, Sikand G, Aspry KE, Soffer DE, Willard KE, Maki KC. Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force. J Clin Lipidol. 2019 Sep-Oct;13(5):689-711.e1. [PubMed: 31611148]

27.

Buehler LA, Noe D, Knapp S, Isaacs D, Pantalone KM. Ketogenic diets in the management of type 1 diabetes: Safe or safety concern? Cleve Clin J Med. 2021 Oct 01;88(10):547-555. [PubMed: 34598919]

28.

American Diabetes Association Professional Practice Committee. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2025. Diabetes Care. 2025 Jan 01;48(1 Suppl 1):S86-S127. [PMC free article: PMC11635047] [PubMed: 39651983]

29.

Scholl-Bürgi S, Höller A, Pichler K, Michel M, Haberlandt E, Karall D. Ketogenic diets in patients with inherited metabolic disorders. J Inherit Metab Dis. 2015 Jul;38(4):765-73. [PubMed: 26109259]

30.

Watanabe M, Tuccinardi D, Ernesti I, Basciani S, Mariani S, Genco A, Manfrini S, Lubrano C, Gnessi L. Scientific evidence underlying contraindications to the ketogenic diet: An update. Obes Rev. 2020 Oct;21(10):e13053. [PMC free article: PMC7539910] [PubMed: 32648647]

31.

Reinhart J. Early Detection of Diabetic Ketoacidosis by Breathalyzer in a Sailor Reporting for Duty. Mil Med. 2019 Dec 01;184(11-12):e951-e952. [PubMed: 31141143]

32.

Watterson JH. Assessment of response of the Intoxilyzer 8000C to volatiles of forensic relevance in vitro, part I: acetone, isopropanol, and methanol. J Anal Toxicol. 2009 Mar;33(2):109-17. [PubMed: 19239737]

33.

Lopes Neri LC, Guglielmetti M, Fiorini S, Pasca L, Zanaboni MP, de Giorgis V, Tagliabue A, Ferraris C. Adherence to ketogenic dietary therapies in epilepsy: A systematic review of literature. Nutr Res. 2024 Jun;126:67-87. [PubMed: 38631175]

34.

Lightstone L, Shinnar S, Callahan CM, O'Dell C, Moshe SL, Ballaban-Gil KR. Reasons for failure of the ketogenic diet. J Neurosci Nurs. 2001 Dec;33(6):292-5. [PubMed: 11776710]

35.

García-Gorrita C, Soriano JM, Merino-Torres JF, San Onofre N. Anthropometric Trajectories and Dietary Compliance During a Personalized Ketogenic Program. Nutrients. 2025 Apr 27;17(9) [PMC free article: PMC12073587] [PubMed: 40362784]

36.

Patikorn C, Saidoung P, Pham T, Phisalprapa P, Lee YY, Varady KA, Veettil SK, Chaiyakunapruk N. Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials. BMC Med. 2023 May 25;21(1):196. [PMC free article: PMC10210275] [PubMed: 37231411]

37.

Alum EU, Izah SC, Betiang PA, Paul-Chima Ugwu O, Ainebyoona C, Uti DE, Echegu DA, Alum BN. The Ketogenic Diet in Obesity Management: Friend or Foe? Cell Biochem Biophys. 2025 Aug 29; [PubMed: 40879882]

38.

Garofalo V, Barbagallo F, Cannarella R, Calogero AE, La Vignera S, Condorelli RA. Effects of the ketogenic diet on bone health: A systematic review. Front Endocrinol (Lausanne). 2023;14:1042744. [PMC free article: PMC9932495] [PubMed: 36817595]

39.

Best CM, Hsu S. Effects of very low carbohydrate ketogenic diets on skeletal health. Curr Opin Endocrinol Diabetes Obes. 2023 Aug 01;30(4):184-191. [PubMed: 37132326]

40.

Lima MC, Gabiatti MP, Moreira JD, Ribeiro LC, Lunardi MDS, Lin K, Venske DK. Ketogenic diet, epilepsy and cognition: what do we know so far? A systematic review. Nutr Rev. 2022 Sep 05;80(10):2064-2075. [PubMed: 35535020]

41.

Dyńka D, Kowalcze K, Charuta A, Paziewska A. The Ketogenic Diet and Cardiovascular Diseases. Nutrients. 2023 Jul 28;15(15) [PMC free article: PMC10421332] [PubMed: 37571305]

42.

Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev. 2016 Feb 09;2:CD001903. [PubMed: 26859528]

43.

Rodell A, Rasmussen LJ, Bergersen LH, Singh KK, Gjedde A. Natural selection of mitochondria during somatic lifetime promotes healthy aging. Front Neuroenergetics. 2013;5:7. [PMC free article: PMC3740293] [PubMed: 23964235]

44.

Gower BA, Chandler-Laney PC, Ovalle F, Goree LL, Azziz R, Desmond RA, Granger WM, Goss AM, Bates GW. Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS. Clin Endocrinol (Oxf). 2013 Oct;79(4):550-7. [PMC free article: PMC4111472] [PubMed: 23444983]

45.

Phillips MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, Lynch CDP. Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial. Mov Disord. 2018 Aug;33(8):1306-1314. [PMC free article: PMC6175383] [PubMed: 30098269]

46.

Tobias DK, Chen M, Manson JE, Ludwig DS, Willett W, Hu FB. Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015 Dec;3(12):968-79. [PMC free article: PMC4667723] [PubMed: 26527511]

47.

Oliveira CLP, Mattingly S, Schirrmacher R, Sawyer MB, Fine EJ, Prado CM. A Nutritional Perspective of Ketogenic Diet in Cancer: A Narrative Review. J Acad Nutr Diet. 2018 Apr;118(4):668-688. [PubMed: 28366810]

48.

Barrea L, Caprio M, Tuccinardi D, Moriconi E, Di Renzo L, Muscogiuri G, Colao A, Savastano S., Obesity Programs of nutrition, Education, Research and Assessment (OPERA) group. Could ketogenic diet "starve" cancer? Emerging evidence. Crit Rev Food Sci Nutr. 2022;62(7):1800-1821. [PubMed: 33274644]

49.

Ivan CR, Messina A, Cibelli G, Messina G, Polito R, Losavio F, Torre E, Monda V, Monda M, Quiete S, Casula E, Napoli N, Defeudis G. Italian Ketogenic Mediterranean Diet in Overweight and Obese Patients with Prediabetes or Type 2 Diabetes. Nutrients. 2022 Oct 18;14(20) [PMC free article: PMC9610411] [PubMed: 36297044]

50.

McAllister MJ, Waldman HS, Rentería LI, Gonzalez AE, Butawan MB, Bloomer RJ. Acute coffee ingestion with and without medium-chain triglycerides decreases blood oxidative stress markers and increases ketone levels. Can J Physiol Pharmacol. 2020 Apr;98(4):194-200. [PubMed: 31689118]

Disclosure: Sharon Daley declares no relevant financial relationships with ineligible companies.

Disclosure: Wajeed Masood declares no relevant financial relationships with ineligible companies.

Disclosure: Pavan Annamaraju declares no relevant financial relationships with ineligible companies.

Disclosure: Mahammed Khan Suheb declares no relevant financial relationships with ineligible companies.